Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Renal Dosing Protocol - Renal Dosing Protocol

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3
At a glance
Powered by AI
The document provides guidance on adjusting drug dosages based on a patient's estimated renal function for drugs commonly used in the ICU. Renal function is estimated based on creatinine clearance and drugs are categorized into dosing recommendations for different levels of renal function.

The protocol provides guidance for dosing adjustments for over 40 different drugs based on a patient's renal function.

Renal function is estimated based on creatinine clearance (CrCl) and categorized into ranges of mL/min for dosing recommendations: <10, 10-25, 25-50, >30, >50, 30-60, and normal renal function.

Renal Dosing Protocol Drug List (revised 8/04) Based on the ICU Renal Dosing Protocol, for ICU

patients drugs on this list may be automatically dose-adjusted by the Clinical Pharmacist according to the patients renal function.
Drug <10 mL/min Acyclovir (IV)A Herpes Simplex Encephalitis Acyclovir (PO)A Herpes Simplex Infection Acyclovir (PO)A Herpes Zoster Amoxicillin (PO)AB
Amoxicillin/Clavulanat A e (PO) 10 mL/min Consider loading dose then

Estimated CrCl and Recommended Renal Dosing 10-25 mL/min 25-50 >30 >50 30-60 mL/min mL/min mL/min mL/min
10 15 mg/kg Q24H

Normal Renal Function

5 - 7.5 mg/kg Q24 H

10-15 mg/kg Q12H

10-15 mg/kg Q8H

200 mg BID 800 mg BID 250-500mg QDay 250-500 mg QDay 2g Q12-24H 1.5-3g Q24-48 H 250-500 mg Q8H 1-2g Q 24-48H 250-500 mg Q 24 H 1g Q 24 H 1-2 g Q24H

10 mL/min

200mg Q4H 5X per Day 800mg TID


10-30 mL/min > 25 mL/min

800 mg Q4H 5X per Day


> 30 mL/min

250-500 mg BID
10-30 mL/min

250-500 mg TID
> 30 mL/min

250-500 mg BID
10-50ml/min

875 mg BID
>50ml/min

Ampicillin (IV)B
Ampicillin/Sulbactam B (IV)

2g Q 6-12H
10-50 mL/min

2g Q 6H
> 50 mL/min

1.5-3g Q 12-24H
10-30 mL/min > 30 mL/min

1.5-3g Q 6-8 H 1g Q 8 H
> 50 mL/min

Aztreonam (IV)P
Initial loading dose 1-2g

500-1000 mg Q 8 H
10-50 mL/min

Cefazolin (IV)S Cefepime (IV)P Normal Dosing Cefepime (IV)P Febrile Neutropenia Cefotaxime (IV)D

1-2g Q12H
11-29 mL/min

500 mg-1g Q 24 H
11-29 mL/min

2g Q 24H
10-50 mL/min

1-2g Q8H (2g only if severe) 500mg- >60 mL/min 500mg2g Q 24 H 2g Q12 H >60 mL/min 2g Q 12 H 2g Q 8 H
> 50 mL/min Moderate-Severe: 1-2g Q Severe: 2g Q 6-8 H Life Threatening: 2g IV Q 4 H (12g Max)

1-2g Q8-12H

8-12 H

Cefoxitin (IV) Cefpodoxime (PO)P Ceftazidime (IV)B

1 g Q 24-48 H
< 30 mL/min

1-2 g Q 12-24 H

1-2 g Q 8-12 H
> 30 mL/min

1-2 g Q 8H

100-400 mg QD < 15 mL/min 1-2g Q 48 H

100-400 mg BID
10-50 mL/min > 50 mL/min

Ceftriaxone (IV)P Cefuroxime (IV)P

1g load then 500mg Q 24H


1020ml/min

1-2g Q 24-48 H

1-2g Q 8-12 H

No renal adjustment necessary 1-2g Q24H 750 mg Q 24H


>20ml/min

Cephalexin (PO)A Ciprofloxacin (IV)B

750mg Q 12 H 250mg Q 12 H
< 5 mL/min:

750 mg-1.5g Q 8 H
11 - 40 mL/min > 40 mL/min

500 mg Q 8-12 H
10-50 mL/min

500 mg QID
> 50 mL/min

250mg Q 24 H 200mg Q 12 H

200-300 mg Q 12 H
10-50 mL/min

400 mg Q 12 H Severe or febrile neutropenia: 400 mg Q 8 H


> 50 mL/min

Ciprofloxacin (PO)B
If CrCl < 30mL/min do not use 750mg tabs

250mg Q12H

250-500 mg Q 12 H

500-750 mg Q 12 H

G:\Share\Pharmacy Admin\Policy & Procedure Manual\Ready to sign\Ready for FormWeb\Renal Dosing Protocol Drug List .doc Revised 6/04

Drug <10 mL/min Clarithromycin (PO)D


Enoxaparin (SQ)P Lovenox
< 30 mL/min

Estimated CrCl and Recommended Renal Dosing 10-25 25-50 >30 >50 mL/min mL/min mL/min mL/min
30 mL/min

Normal Renal Function

125-250 mg Q 12 H or 250-500 mg Q 24 H
< 30 mL/min

250-500 mg Q 12 H
> 30 mL/min

Prophylaxis: 30 mg Q 24 H Treatment: 1 mg/kg Q 24 H


< 30 mL/min

Ertapenem (IV)P Erythromycin Lactobionate (IV)S


Monitor for signs of ototoxicity

Prophylaxis: 40 mg QDay or 30mg BID Treatment: 1mg/kg Q 12H or 1.5mg/kg QDay


> 30 mL/min

500 mg Q 24 H 10 mL/min 125-375mg 250-500 mg Q 6 H Q6H 125-375mg Q6H


< 50 mL/min 10 mL/min

1g Q 24 H

Erythromycin Base (PO)S


Monitor for signs of ototoxicity

250-500 mg Q 6 H
> 50 mL/min

Famotidine (IV/PO)P Pepcid

20 mg Q 24 H
or dose recommended for indication
< 50 mL/min

20 mg Q12 H
> 50 mL/min

Fluconazole (IV/PO)A

200-400 mg load, then 50-100 mg QDay 1.25 mg/kg Q 24H 0.625 mg/kg Q 24 H 500 mg QDay 125-250 mg Q 12 H
10-49 mL/min 25-49 mL/min

Ganciclovir (IV)AP
Induction CMV retinitis

200-400 mg load, then 100-200 mg QDay Severe: 800 mg load, then 400 mg QDay
50-69 mL/min > 70 mL/min

Ganciclovir (IV)D
Maintenance CMV retinitis

2.5 mg/kg Q 24 H
25-49 mL/min

2.5 mg/kg Q 12 H
50-69 mL/min

5 mg/kg Q 12 H
> 70 mL/min

Ganciclovir (PO)A
Maintenance CMV retinitis

1.25 mg/kg Q 24 H
25-49 mL/min

2.5 mg/kg Q 24 H
50-69 mL/min

5mg/kg Q 24 H
> 70 mL/min

500 mg BID

500 mg TID
> 50 mL/min

1g TID

Imipenem/Cilastatin S (IV) Primaxin


Should be use with caution, if at all, in renal failure due to an increased risk of seizures. Meropenem is preferred in renal failure.

250 mg Q 6-12 H

250-500 mg Q 6-8 H

Ketorolac (IM/IV) P
Toradol

Contraindicated in patients with advanced renal impairment and patients at risk for renal failure because of volume depletion.

50 mL/min

15-30 mg Q 6 H
> 50 mL/min

Combined use of IV/PO should not exceed 5 days

Levofloxacin (IV/PO)D Meropenem (IV)P Metoclopramide (IV/PO)P


Reglan

< 20 mL/min

20-49 mL/min

500 mg load, then 250 mg Q 48 H

500 mg load, then 250 mg Q 24 H


26-50 mL/min

500 mg Q24H
> 50 mL/min

500mg Q 24 H
< 40 mL/min

500mg Q 12 H

1g Q 12 H
> 40mL/min

1g Q 8 H 10-20 mg Q 6 H

5-10 mg Q 6 H
< 10 mL/min > 10 mL/min

Metronidazole (IV)BS

50% of Usual Dose


See Note

100% of usual dose


Note: Usual dose per reference: 7.5mg/kg (~500mg) Q 6 H Other doses are commonly used in clinical practice

G:\Share\Pharmacy Admin\Policy & Procedure Manual\Ready to sign\Ready for FormWeb\Renal Dosing Protocol Drug List .doc Revised 6/04

Drug < 10 mL/min Nitrofurantoin (PO)B Nitrofurantoin ER (PO)B Penicillin G (IV)A Normal Dose Penicillin G (IV)A Serious Infections Penicillin V (PO)D Piperacillin (IV)D Piperacillin/ Tazobactam (IV)S Rifampin (IV)/(PO)BD
Endocarditis requires special dosing

Estimated CrCl and Recommended Renal Dosing 10-25 25-50 >30 >50 30-60 mL/min mL/min mL/min mL/min mL/min
> 50 mL/min

Normal Renal Function

Not recommended with CrCl 50mL/min Not recommended with CrCl 50mL/min 1-4 Million units Q 12-18 H 500,000 -2 Million Units Q4H
< 10 mL/min 10-50 mL/min

50-100 mg Q 6 H Prophylaxis: 100mg QDay


> 50 mL/min

100 mg BID
> 50 mL/min

1-4 Million Units Q 8-12 H


10-50 mL/min

1-4 Million Units Q 6-8 H


> 50 mL/min

1-4 Million Units Q 4 H


> 10 mL/min

1-4 Million Units Q 4 H

250-500 mg Q8H
<20 mL/min

250-500 mg Q 6 H
21-39 mL/min > 40 mL/min

3-4g Q 12 H 2.25g Q8H


50 mL/min

3-4g Q 8 H
10-49 mL/min

3-4g Q 4-6 H
> 50 mL/min

2.25g Q6H

3.375g Q 6 H
> 50 mL/min

300-600mg Q 24 H
< 15 mL/min 15-30 mL/min > 30 mL/min

600mg Q 24 H

Trimethoprim/ Sulfamethoxazole (TMP/Sulfa)D


Dosing based on TMP -For PCP Treatment

Trimethoprim/ Sulfamethoxazole (TMP/Sulfa)D


Dosing based on TMP Component --For PCP Prophylaxis

15-20 mg/kg/dose Q 48 H or 7-10 mg/kg/day divided Q12-24 H < 15 mL/min

15-20 mg/kg/day divided Q 6-8H X 48 H then, 7-10 mg/kg/day divided Q 12 H

15-20 mg/kg/day divided Q 6-8 H

15-30 mL/min

>30 mL/min

5mg/kg Q 48-72 H

5mg/kg Q 24-48 H for 3-7 doses/week

5mg/kg Q 24 H for 3-7doses/week

Trimethoprim/ Sulfamethoxazole (TMP/Sulfa)D


Dosing based on TMP Component

< 15 mL/min 8-12 mg/kg/dose Q 48 H (or 4-6 mg/kg/day divided Q 12-24H)


< 30 mL/min

15-30 mL/min

> 30 mL/min

8-12 mg/kg/day divided Q 12 H x 1-2days then 4-6mg/kg Q 24 H

8-12 mg/kg/day divided Q 12 H X 14 days then 4-6 mg/kg Q 24 H

Vancomycin (IV) Adult weight > 60kg* Vancomycin (IV) Adult weight < 60kg*
References
A B

30-60 mL/min

1g
*frequency based on trough level
< 30 mL/min

1g Q 24H
30-60 mL/min

60 mL/min

1g Q 12 H
60 mL/min

20mg/kg (max 1500mg)


*frequency based on trough level

15mg/kg Q 24 H
(round to 250mg increments)

15mg/kg Q 12 H (round to 250mg increments)

McEvoy G, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-Systems Pharmacists, Inc; 2003. th Bennett GR, Arnoff TA, Golper et al. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults, 4 ed. Philadelphia: American College of Physicians; 1999. D Gelman CR, Rumack BH, Hutchison TA, eds. Drugdex System. Englewood, CO: Micromedex, Inc. Edition Expires 03/2003. P st Physicians Desk Reference. 51 ed. Montvale, NJ: Medical Economics Company, Inc; 2003. S Gilbert D. Moellering R. Sande M. The Sanford Guide to Antimicrobial Therapy. Hyde Park, VT: Antimicrobial Therapy Inc; 2003.

G:\Share\Pharmacy Admin\Policy & Procedure Manual\Ready to sign\Ready for FormWeb\Renal Dosing Protocol Drug List .doc Revised 6/04

You might also like